These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 4471695)

  • 1. An endoperoxide aggregator (Lass), formed in platelets in response to thrombotic stimuli: purification, identification and unique biological significance.
    Willis AL; Vane FM; Kuhn DC; Scott CG; Petrin M
    Prostaglandins; 1974 Dec; 8(6):453-507. PubMed ID: 4471695
    [No Abstract]   [Full Text] [Related]  

  • 2. Dihomo-gamma-linolenate suppresses platelet aggregation when administered in vitro or in vivo.
    Willis AL; Comai K; Kuhn DC; Paulsrud J
    Prostaglandins; 1974 Dec; 8(6):509-19. PubMed ID: 4462154
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostaglandins in platelet function.
    Smith JB; Ingerman C; Kocsis JJ; Silver MJ
    Thromb Res; 1974 Jun; 4(0):suppl 1:49-55. PubMed ID: 4602232
    [No Abstract]   [Full Text] [Related]  

  • 4. Prostaglandin E2 potentiation of platelet aggregation induced by LASS endoperoxide: absent in storage pool disease, normal after aspirin ingestion.
    Weiss HJ; Willis AL; Kuhn D; Brand H
    Br J Haematol; 1976 Feb; 32(2):257-72. PubMed ID: 1247498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetylenic analog of arachidonate that acts like aspirin on platelets.
    Willis AL; Kuhn DC; Weiss HJ
    Science; 1974 Jan; 183(4122):327-30. PubMed ID: 4809077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arachidonic acid-induced human platelet aggregation and prostaglandin formation.
    Silver MJ; Smith JB; Ingerman C; Kocsis JJ
    Prostaglandins; 1973 Dec; 4(6):863-75. PubMed ID: 4205973
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of epinephrine on the aggregation response of aspirin-treated platelets.
    Rao GH; Johnson GJ; White JG
    Prostaglandins Med; 1980 Jul; 5(1):45-58. PubMed ID: 7403340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of saturated and unsaturated fatty acids on blood platelet aggregation in vitro and after injection into rabbits.
    Prost RJ; Dvojakovic M; Bara L; Samama M
    Acta Univ Carol Med Monogr; 1972; 53():403-7. PubMed ID: 4670745
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclic AMP inhibits synthesis of prostaglandin endoperoxide (PGG2) in human platelets.
    Malmsten C; Granström E; Samuelsson B
    Biochem Biophys Res Commun; 1976 Jan; 68(2):569-76. PubMed ID: 175797
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro evaluation of inhibitors of platelet release and aggregation.
    Rosenberg JC; Sell TL
    Arch Surg; 1975 Aug; 110(8):980-3. PubMed ID: 168838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of labile aggregation-stimulating substance (LASS) and platelet aggregation in diabetes mellitus.
    Colwell JA; Chambers A; Laimins M
    Diabetes; 1975 Jul; 24(7):684-7. PubMed ID: 1158034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malondialdehyde formation as an indicator of prostaglandin production by human platelets.
    Smith JB; Ingerman CM; Silver MJ
    J Lab Clin Med; 1976 Jul; 88(1):167-72. PubMed ID: 932533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrin-induced release of platelet serotonin.
    Orloff KG; Michaeli D
    Am J Physiol; 1976 Aug; 231(2):344-50. PubMed ID: 961885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandins and platelet function.
    Salzman EW
    Adv Prostaglandin Thromboxane Res; 1976; 2():767-80. PubMed ID: 185888
    [No Abstract]   [Full Text] [Related]  

  • 16. Formation of an intermediate in prostaglandin biosynthesis and its association with the platelet release reaction.
    Smith JB; Ingerman C; Kocsis JJ; Silver MJ
    J Clin Invest; 1974 May; 53(5):1468-72. PubMed ID: 4825236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo functions of thrombin-treated platelets.
    Reimers HJ; Kinlough-Rathbone RL; Cazenave JP; Senyi AF; Hirsh J; Packham MA; Mustard JF
    Thromb Haemost; 1976 Feb; 35(1):151-66. PubMed ID: 785686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of platelet aggregation by drugs.
    Glusa E
    Acta Univ Carol Med Monogr; 1972; 52():83-6. PubMed ID: 4669829
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of platelet membrane antibodies on aggregation and release.
    Kaplan KL; Nachman RL
    Br J Haematol; 1974 Dec; 28(4):551-60. PubMed ID: 4477019
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of peroxidized arachidonic acid upon human platelet aggregation.
    Mickel HS; Horbar J
    Lipids; 1974 Feb; 9(2):68-71. PubMed ID: 4205771
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.